Adaptive Biotechnologies (ADPT) Market Capitalization (2019 - 2026)

Adaptive Biotechnologies has disclosed Market Capitalization across 8 years of filings, most recently posting $3.4 billion for Q2 2026.

• In Q2 2026, Market Capitalization rose 92.37% year-over-year to $3.4 billion; the TTM figure through Jun 2026 stood at $3.4 billion (up 92.37% YoY), while the FY2025 annual figure was $2.5 billion, up 182.14% from the prior year.
• Market Capitalization came in at $3.4 billion for Q2 2026 at Adaptive Biotechnologies, up from $2.2 billion in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $3.4 billion in Q2 2026 to a low of $473.1 million in Q1 2024.
• Average Market Capitalization over 5 years is $1.4 billion, with a median of $1.1 billion recorded in 2022.
• Year-over-year, Market Capitalization plunged 79.9% in 2022 and jumped 232.24% in 2025.
• Over 5 years, Market Capitalization stood at $1.1 billion in 2022, then tumbled by 34.98% to $710.9 million in 2023, then rose by 24.51% to $885.2 million in 2024, then soared by 182.14% to $2.5 billion in 2025, then surged by 36.62% to $3.4 billion in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $3.4 billion in Q2 2026, $2.2 billion in Q1 2026, and $2.5 billion in Q4 2025.